AboutContactTerms & Privacy
© 2026 Coverager
All Rights Reserved

Kanglin Biotech

Researcher and developer of Gene therapy innovative drug.

Headquarters
Hangzhou, Zhejiang, China
Founded
2015
Operating Status
Active
Ownership Type
Links
Number of funding rounds 2
Number of investors 3
Total funding amount $21.06M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.